{
  "id": 2393360,
  "title": "Industry Voices—Hospital AI committees are asking the wrong privacy question",
  "url": "https://urgent.news/2026/08/21/industry-voices-hospital-ai-committees-are-asking-the-wrong-privacy",
  "topic": "ai",
  "section": "AI",
  "published": "2026-08-21T13:14:25.000Z",
  "source": {
    "name": "Fierce Healthcare",
    "slug": "fierce-healthcare",
    "url": "https://www.fiercehealthcare.com/ai-and-machine-learning/industry-voices-hospital-ai-committees-are-asking-wrong-privacy-question"
  },
  "original_language": "en",
  "account": "Hospitals are establishing AI committees to handle the legitimate concern of adopting AI models without compromising patient information. However, these committees often only focus on one critical question: whether protected health information (PHI) was utilized to train the model. While both large language models fine-tuned on clinical notes and computer-vision models trained to detect body parts may have used PHI during development, their purposes and outputs differ significantly. HIPAA mandates that business associates can only use PHI according to their agreements with covered entities and must apply appropriate safeguards. Yet, this legally required baseline does not mark the end of the privacy analysis.\n\nThe more crucial question is: What realistic pathway exists for the deployed model to expose patient information? One-size-fits-all review processes may seem unnecessary yet can mislead hospitals into believing that all AI models pose similar privacy risks. For generative models, a generic checklist may foster false confidence, as it may overlook the model's most significant exposure pathways such as arbitrary prompt entry and adaptive querying. Similarly, it may over-regulate narrow models that lack generative capabilities, prompts, or exposure of model weights, which could actually decrease privacy exposure.\n\nBlocking controlled training on PHI, while intended to enhance privacy, could also reduce the redaction accuracy and prolong the manual handling of identifiable data. Therefore, collapsing the distinction between risk levels can have contradictory effects, undermining AI governance efforts. Narrow AI models fine-tuned to perform specific tasks on de-identified data, and which do not generate outputs or reveal internal representations, may have minimal realistic pathways to expose PHI. Under the Expert Determination method of HIPAA, information may be deemed de-identified when a qualified expert concludes the risk of identification is very small in the specific context. However, this standard is not about mathematical impossibility but about practical risk assessment.\n\nAI privacy review should adopt a practical approach similar to evaluating security, focusing on the model's architecture, implementation, potential attacker access, computational cost, and likelihood of success. Demanding proof of zero theoretical risk, as some security teams may do, is not rigorous risk management. It is risk avoidance ungrounded in probability, potentially obstructing AI models that reduce larger privacy and clinical risks. AI risk is multifaceted, encompassing privacy, security, clinical safety, bias, and operational dependence. A single, undifferentiated privacy review process does not adequately address these distinct dimensions.",
  "summary": "One-size-fits-all review can under-govern high-risk generative AI models while blocking narrow AI models designed to reduce privacy exposure, write Peter Grantcharov and David Knobel.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}